Condom HIV Protection Supported By Panel, Other STDs Inconclusive
This article was originally published in The Tan Sheet
Executive Summary
Latex condom use lowers the risk of acquiring HIV and gonorrhea, but study data on condoms' effectiveness at reducing the risk of other sexually transmitted diseases is inconclusive, according to a recent National Institutes of Health report.
You may also be interested in...
Condoms labeling
"It is critically important that FDA inform consumers that condoms do not provide effective protection against infection that can cause cervical cancer as required by law," Rep. Mark Souder (R-Ind.) maintains in a letter inviting FDA, NCI, CDC and Centers for Medicare & Medicaid Services to a Jan. 28 House Government Reform/Human Resources Subcommittee hearing. Indiana Republican points to a 2001 report by the National Institute of Allergy & Infectious Diseases showing "evidence is currently insufficient" to assess condom use for prevention of HPV, among other STDs (1"The Tan Sheet" July 23, 2001, p. 13). Souder's letter notes that Public Law 106-554, enacted in 2000, mandates that FDA "reexamine existing condom labels...to determine whether the labels are medically accurate regarding the overall effectiveness or lack of effectiveness in preventing sexually transmitted diseases, including HPV." Hearing is slated for 10 a.m. in Room 2154, Rayburn House Office Building...
Condoms labeling
"It is critically important that FDA inform consumers that condoms do not provide effective protection against infection that can cause cervical cancer as required by law," Rep. Mark Souder (R-Ind.) maintains in a letter inviting FDA, NCI, CDC and Centers for Medicare & Medicaid Services to a Jan. 28 House Government Reform/Human Resources Subcommittee hearing. Indiana Republican points to a 2001 report by the National Institute of Allergy & Infectious Diseases showing "evidence is currently insufficient" to assess condom use for prevention of HPV, among other STDs (1"The Tan Sheet" July 23, 2001, p. 13). Souder's letter notes that Public Law 106-554, enacted in 2000, mandates that FDA "reexamine existing condom labels...to determine whether the labels are medically accurate regarding the overall effectiveness or lack of effectiveness in preventing sexually transmitted diseases, including HPV." Hearing is slated for 10 a.m. in Room 2154, Rayburn House Office Building...
Condoms labeling
"It is critically important that FDA inform consumers that condoms do not provide effective protection against infection that can cause cervical cancer as required by law," Rep. Mark Souder (R-Ind.) maintains in a letter inviting FDA, NCI, CDC and Centers for Medicare & Medicaid Services to a Jan. 28 House Government Reform/Human Resources Subcommittee hearing. Indiana Republican points to a 2001 report by the National Institute of Allergy & Infectious Diseases showing "evidence is currently insufficient" to assess condom use for prevention of HPV, among other STDs (1"The Tan Sheet" July 23, 2001, p. 13). Souder's letter notes that Public Law 106-554, enacted in 2000, mandates that FDA "reexamine existing condom labels...to determine whether the labels are medically accurate regarding the overall effectiveness or lack of effectiveness in preventing sexually transmitted diseases, including HPV." Hearing is slated for 10 a.m. in Room 2154, Rayburn House Office Building...